11 May 2026
Validated human colon research shows butyrate-forward microbiome engagement without fiber or live bacteria.
Digestive ingredients often reference the microbiome, but few demonstrate how they meaningfully interact with it. In two published human clinical studies, Digexin demonstrated improvements in gastrointestinal regularity, transit time, and constipation-related symptoms.
Now, in a validated ex vivo human colon simulation, Digexin was shown to engage existing gut microbiota, driving beneficial fermentation and metabolite production linked to digestive comfort and gut integrity. Thee findings add mechanistic insight to Digexin's established clinical benefits.
Brochure
PDF 692 kB